BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 29226596)

  • 1. State of the art review: Chemotherapy-induced cardiotoxicity in children.
    Loar RW; Noel CV; Tunuguntla H; Colquitt JL; Pignatelli RH
    Congenit Heart Dis; 2018 Jan; 13(1):5-15. PubMed ID: 29226596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chemotherapy-induced cardiotoxicity: Incidence, diagnosis and prevention].
    Nelson-Veniard M; Thambo JB
    Bull Cancer; 2015; 102(7-8):622-6. PubMed ID: 25935231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiotoxicity of cancer chemotherapy: implications for children.
    Simbre VC; Duffy SA; Dadlani GH; Miller TL; Lipshultz SE
    Paediatr Drugs; 2005; 7(3):187-202. PubMed ID: 15977964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardioprotection in the Modern Era of Cancer Chemotherapy.
    Godishala A; Yang S; Asnani A
    Cardiol Rev; 2018; 26(3):113-121. PubMed ID: 29608498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anthracycline-Related Heart Failure: Certain Knowledge and Open Questions : Where Do we Stand with Chemotherapyinduced Cardiotoxicity?
    Robinson EL; Azodi M; Heymans S; Heggermont W
    Curr Heart Fail Rep; 2020 Dec; 17(6):357-364. PubMed ID: 32964378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging methods for detection of chemotherapy-associated cardiotoxicity and dysfunction.
    Ong DS; Scherrer-Crosbie M; Coelho-Filho O; Francis SA; Neilan TG
    Expert Rev Cardiovasc Ther; 2014 Apr; 12(4):487-97. PubMed ID: 24650314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluoropyrimidine-Associated Cardiotoxicity.
    Kanduri J; More LA; Godishala A; Asnani A
    Cardiol Clin; 2019 Nov; 37(4):399-405. PubMed ID: 31587781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Biomarkers in Cardio-Oncology.
    Ananthan K; Lyon AR
    J Cardiovasc Transl Res; 2020 Jun; 13(3):431-450. PubMed ID: 32642841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiotoxicity of systemic agents used in breast cancer.
    Ades F; Zardavas D; Pinto AC; Criscitiello C; Aftimos P; de Azambuja E
    Breast; 2014 Aug; 23(4):317-28. PubMed ID: 24794210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of anthracycline cardiotoxicity in children and adults.
    Grenier MA; Lipshultz SE
    Semin Oncol; 1998 Aug; 25(4 Suppl 10):72-85. PubMed ID: 9768828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticancer agents and cardiotoxicity.
    Ng R; Better N; Green MD
    Semin Oncol; 2006 Feb; 33(1):2-14. PubMed ID: 16473642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of biomarkers in the early detection of anthracycline-induced cardiotoxicity in children: a review of the literature.
    Mavinkurve-Groothuis AM; Kapusta L; Nir A; Groot-Loonen J
    Pediatr Hematol Oncol; 2008 Sep; 25(7):655-64. PubMed ID: 18850478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardio-Oncology: Progress in Diagnosis and Treatment of Cardiac Dysfunction.
    Tromp J; Steggink LC; Van Veldhuisen DJ; Gietema JA; van der Meer P
    Clin Pharmacol Ther; 2017 Apr; 101(4):481-490. PubMed ID: 28073142
    [No Abstract]   [Full Text] [Related]  

  • 14. Myocardial Protection During Cardiotoxic Chemotherapy.
    Witteles RM; Bosch X
    Circulation; 2015 Nov; 132(19):1835-45. PubMed ID: 26553713
    [No Abstract]   [Full Text] [Related]  

  • 15. Scintigraphic techniques for early detection of cancer treatment-induced cardiotoxicity.
    de Geus-Oei LF; Mavinkurve-Groothuis AM; Bellersen L; Gotthardt M; Oyen WJ; Kapusta L; van Laarhoven HW
    J Nucl Med; 2011 Apr; 52(4):560-71. PubMed ID: 21421717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of biomarkers in chemotherapy-induced cardiotoxicity.
    Cardinale D; Sandri MT
    Prog Cardiovasc Dis; 2010; 53(2):121-9. PubMed ID: 20728699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cardiotoxicity of anticancer agents.
    Von Hoff DD; Rozencweig M; Piccart M
    Semin Oncol; 1982 Mar; 9(1):23-33. PubMed ID: 7071608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilizing cardiac biomarkers to detect and prevent chemotherapy-induced cardiomyopathy.
    Singh D; Thakur A; Tang WH
    Curr Heart Fail Rep; 2015 Jun; 12(3):255-62. PubMed ID: 25869733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heart failure and chemotherapeutic agents.
    Piper S; McDonagh T
    Future Cardiol; 2015 Jul; 11(4):453-70. PubMed ID: 26234158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiotoxicity of antineoplastic agents: what is the present and future role for imaging?
    Markman TM; Markman M
    Curr Oncol Rep; 2014; 16(8):396. PubMed ID: 24992733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.